Literature DB >> 11603748

Is homologous blood transfusion a risk factor for infection after hip replacement?

D Steinitz1, E J Harvey, R K Leighton, D P Petrie.   

Abstract

OBJECTIVES: To assess the risk of postoperative infection associated with blood transfusion in patients who undergo primary total hip arthroplasty.
DESIGN: A retrospective cohort study.
SETTING: Victoria General Hospital, Halifax, (a tertiary-care centre). PATIENTS: All patients who underwent primary total hip replacement between 1990 and 1995 (N = 1206).
INTERVENTIONS: Hip replacement with or without perioperative blood transfusion. OUTCOME MEASURES: The rate of postoperative infection, the number of blood transfusions, patient age and sex, duration of surgery and the surgeon who performed the procedure. Victoria General Hospital medical records, the transfusion services record and the Dalhousie University Hip Study databases were integrated and analyzed using a standard statistical package.
RESULTS: The incidence of infection postoperative was 9.9% overall, 8.4% in patients receiving no transfusion, and 14% in those receiving homologous transfusion (p = 0.035). There were no infections in the 11 patients who received an autologous blood transfusion. Significant predictors of postoperative infection were sex, age and duration surgery; these were not confounding variables multivariate analysis). Neither the operating surgeon nor the blood product transfused affected the infection rate.
CONCLUSIONS: These findings suggest an increased risk of postoperative infection in patients who undergo primary hip replacement and receive homologous blood transfusions perioperatively.

Entities:  

Mesh:

Year:  2001        PMID: 11603748      PMCID: PMC3692642     

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  9 in total

1.  Efficacy and cost-effectiveness of a blood salvage system in primary total knee arthroplasty--a retrospective match-controlled chart review.

Authors:  Clifford Kent Boese; Theresa J Gallo; Marcia Weis; Rebecca Baker; Carla J Plantikow; Brian Cooley
Journal:  Iowa Orthop J       Date:  2011

Review 2.  Risk factors for periprosthetic joint infection following primary total hip or knee arthroplasty: a meta-analysis.

Authors:  Lingde Kong; Junming Cao; Yingze Zhang; Wenyuan Ding; Yong Shen
Journal:  Int Wound J       Date:  2016-07-10       Impact factor: 3.315

3.  [Necessity for blood transfusion in head and neck surgery].

Authors:  P Jecker; A Melzer; W E Hitzler
Journal:  HNO       Date:  2005-11       Impact factor: 1.284

4.  Efficacy and economics of postoperative blood salvage in patients undergoing elective total hip replacement.

Authors:  Saqeb B Mirza; Jon Campion; John H Dixon; Sukhmeet S Panesar
Journal:  Ann R Coll Surg Engl       Date:  2007-11       Impact factor: 1.891

5.  Blood Transfusion Incidence, Risk Factors, and Associated Complications in Surgical Treatment of Hip Dysplasia.

Authors:  Brandon A Sherrod; Dustin K Baker; Shawn R Gilbert
Journal:  J Pediatr Orthop       Date:  2018-04       Impact factor: 2.324

6.  The effects of blood transfusion on renal functions in orthopaedic surgery.

Authors:  Ismail Safa Satoglu; Serkan Akcay; Levent Horoz; Erol Kaya; Ahmet Karakasli; Eyad Skiak; Onur Basci
Journal:  Pak J Med Sci       Date:  2015 Jul-Aug       Impact factor: 1.088

7.  The effect of perioperative blood transfusion on kidney functions in total knee Arthroplasty.

Authors:  Baran Sen; Ramadan Ozmanevra
Journal:  Pak J Med Sci       Date:  2019       Impact factor: 1.088

8.  Outcomes, Microbiology and Antimicrobial Usage in Pressure Ulcer-Related Pelvic Osteomyelitis: Messages for Clinical Practice.

Authors:  Clark D Russell; Shao-Ting Jerry Tsang; Alasdair Hamish R W Simpson; Rebecca K Sutherland
Journal:  J Bone Jt Infect       Date:  2020-03-26

9.  Reducing surgical site infection in arthroplasty of the lower limb: A multi-disciplinary approach.

Authors:  R Johnson; S S Jameson; R D Sanders; N J Sargant; S D Muller; R M D Meek; M R Reed
Journal:  Bone Joint Res       Date:  2013-03-01       Impact factor: 5.853

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.